Table 2:
Resilience Measurement Categories | Common Measures across studies | Bone Marrow Transplant (REBOUND) study only | Dialysis Initiation (ReDI) study only | Knee Replacement (RESTORE) study only |
---|---|---|---|---|
Baseline Contributors | Age, demographics, SES, psychosocial measures, health behaviors, disease meas-ures, medicat-ions, biological measures: immune cell phenotypes, 24-hour catechol-amines, metabol-omic markers | DNA methylation / methylation clock, malignancy type, cytogenetic risk group | Pre-dialysis course, cause of end-stage renal disease, type of dialysis access | Senescent cell markers |
Stressor characteristics | n/a | Dose and type of chemotherapy, total body dose of radiation, conditioning regimen | Interdialytic weight gain, volume removed, dialysis treatment time, dialysate temperature, electrolyte composition, treatment adherence | Anesthesia type & dose, time in surgery, blood loss, fluids administered, transfusion and/or pressor use, use of cement, use of tourniquet, need for intubation, intraoperative temperature, postoperative opioid use |
Static Surrogate Measures * | Phenotypic frailty, SF-36, nutrition (albumin, total cholesterol, vitamin D), Karnofsky performance measure 14 | ECOG15 performance measure, HCT-specific comorbidity index | KDQOL, NYHA self-reported symptoms | Knee Injury and Osteoarthritis Outcome Score (KOOS) |
Dynamic Stimulation Indicator Measures | ACTH stimulat-ion, 24-hour salivary cortisol profile, dynamic ex-vivo response of immune cells, Orthostatic Blood Pressure, Holter monitoring*; Observed Fatigability treadmill test | Oral glucose tolerance test | n/a | Oral glucose tolerance test |
Resilience Phenotype Measures * | Physical function (SPPB, mobility function), accelerometry, cognitive function (MOCA, DSST, NIH Cognition Toolbox), ADLs/IADLs, Pittsburgh fatigability scale, sleep, physiologic markers including inflammatory markers, hormones, clotting factors | |||
Clinical Outcomes | Hospitalization/re-hospitalization, falls, morbidity, mortality | Graft versus host disease, relapse, infection, rehab or skilled nursing facility, new malignancies, post-transplant therapies | Kidney transplantation, transfer to home dialysis modality, uremic symptoms (pruritus, fatigue, anorexia, pain, restless legs), health-related quality of life | NSQIP post-op 30-day complic-ations, LOS until discharge, delirium, dis-charge home, rehab, ambulate unaided 60 days later, independ-ent living; CCI change, patient satisfaction with surgery, post-operative pain |
measured pre and post clinical stressor
Abbreviations: SES=Socioeconomic status; ACTH= Adrenocorticotropic hormone; SPPB=short physical performance battery; MOCA=Montreal cognitive assessment; DSST=Digital symbol substitution test; NIH=National Institute of Health; ADL=Activities of daily living; IADL=instrumental activities of daily living; NSQIP= National Surgical Quality Improvement Program; LOS=Length of stay; KDQOL=Kidney Disease Quality of Life; NYHA=New York Heart Association; HCT=Hematopoietic cell transplantation; DNA=Deoxyribonucleic acid; ECOG=Eastern Cooperative Oncology Group; CCI=Charlson Comorbidity Index. The NIH Cognitive Toolbox tests included in SPRING are Flanker Inhibitory Control and Attention Test; Auditory Verbal Learning Test; and Pattern Comparison Test.